132 related articles for article (PubMed ID: 12790321)
21. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
[TBL] [Abstract][Full Text] [Related]
22. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
Silva EM; Begnami MD; Fregnani JH; Pelosof AG; Zitron C; Montagnini AL; Soares FA
Gastric Cancer; 2008; 11(3):149-59. PubMed ID: 18825309
[TBL] [Abstract][Full Text] [Related]
23. Expression of the E-cadherin/β-catenin/tcf-4 pathway in gastric diseases with relation to Helicobacter pylori infection: clinical and pathological implications.
Yu XW; Xu Q; Xu Y; Gong YH; Yuan Y
Asian Pac J Cancer Prev; 2014; 15(1):215-20. PubMed ID: 24528029
[TBL] [Abstract][Full Text] [Related]
24. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
25. Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.
Abou Khouzam R; Molinari C; Salvi S; Marabelli M; Molinaro V; Orioli D; Saragoni L; Morgagni P; Calistri D; Ranzani GN
Oncotarget; 2017 Mar; 8(12):18811-18820. PubMed ID: 27861150
[TBL] [Abstract][Full Text] [Related]
26. [Molecular diagnosis of gastric cancer].
Yasui W; Yoshida K; Ito H; Tahara E
Gan To Kagaku Ryoho; 1991 Jan; 18(1):7-13. PubMed ID: 1987903
[TBL] [Abstract][Full Text] [Related]
27. New concepts of molecular biology on gastric carcinogenesis.
Kountouras J; Zavos C; Chatzopoulos D
Hepatogastroenterology; 2005; 52(64):1305-12. PubMed ID: 16001683
[TBL] [Abstract][Full Text] [Related]
28. Expression of e-cadherin and catenins in early gastric cancer.
Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
[TBL] [Abstract][Full Text] [Related]
29. Genetic and epigenetic changes in stomach cancer.
Yokozaki H; Yasui W; Tahara E
Int Rev Cytol; 2001; 204():49-95. PubMed ID: 11243597
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
[TBL] [Abstract][Full Text] [Related]
31. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
Pan W; Ishii H; Ebihara Y; Gobe G
J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
[TBL] [Abstract][Full Text] [Related]
32. Alteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancers.
Lim S; Lee HS; Kim HS; Kim YI; Kim WH
Histopathology; 2003 Feb; 42(2):128-36. PubMed ID: 12558744
[TBL] [Abstract][Full Text] [Related]
33. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages.
Wu MS; Shun CT; Sheu JC; Wang HP; Wang JT; Lee WJ; Chen CJ; Wang TH; Lin JT
J Gastroenterol Hepatol; 1998 Mar; 13(3):305-10. PubMed ID: 9570245
[TBL] [Abstract][Full Text] [Related]
35. [New prognostic factors in human gastric carcinomas].
Yasui W; Nakayama H; Kuniyasu H; Ito M; Yokozaki H; Ito H; Tahara E
Gan To Kagaku Ryoho; 1992 Jan; 19(1):26-33. PubMed ID: 1346086
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract][Full Text] [Related]
37. Molecular-pathological prognostic factors of gastric cancer: a review.
Yasui W; Oue N; Aung PP; Matsumura S; Shutoh M; Nakayama H
Gastric Cancer; 2005; 8(2):86-94. PubMed ID: 15864715
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal transition in gastric cancer (Review).
Katoh M
Int J Oncol; 2005 Dec; 27(6):1677-83. PubMed ID: 16273224
[TBL] [Abstract][Full Text] [Related]
39. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
40. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
